title: Tenofovir (Viread(R)) access for poor countries.
abstract: Gilead Sciences announced that it will make its drug tenofovir available at cost in all of Africa, and in some of the poorest countries elsewhere.
authors.forename: John S
authors.initials: JS
authors.lastname: James
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000600:supply & distribution* / Q000627:therapeutic use; D003906:Developing Countries; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000600:supply & distribution* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000600:supply & distribution* / Q000627:therapeutic use; D000068698:Tenofovir
chemical_list: D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine